A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
2023 · Nature Medicine · 213 citations
https://doi.org/10.1038/s41591-023-02234-6
P
Preetesh Jain
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
466
Papers
7.7K
Citations
47
h-index
129
i10-index
Preetesh Jain is an academic researcher. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & CAR-T cell therapy research. The author has an h-index of 47, co-authored 397 publications.
ORCID: 0000-0003-2735-168XPapers by this author
worksOutcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
2003 · British Journal of Cancer · 84 citations
https://doi.org/10.1038/sj.bjc.6601006
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
2022 · Molecular Cancer · 69 citations
https://doi.org/10.1186/s12943-022-01655-0
Advances in the assessment of minimal residual disease in mantle cell lymphoma
2020 · Journal of Hematology & Oncology · 29 citations
https://doi.org/10.1186/s13045-020-00961-8
Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia
2016 · Blood · 20 citations
https://doi.org/10.1182/blood.v128.22.1639.1639
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner
2022 · Current Oncology Reports · 19 citations
https://doi.org/10.1007/s11912-022-01286-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat